Ces informations sont à titre éducatif uniquement. Elles ne constituent pas un avis médical. Consultez toujours un professionnel de santé qualifié.
Description, Posologie, Effets secondaires, Contre-indications. Data from EMA, URPL, openFDA and other regulatory sources.
| Ondansetron | Metoclopramide | |
|---|---|---|
| Substances actives | ONDANSETRON | METOCLOPRAMIDE HYDROCHLORIDE |
| Code ATC | A04AA01 | A03FA01 |
| Forme | — | INJECTABLE |
| Posologie | — | EQ 5MG BASE/ML |
| Voie d'administration | — | INJECTION |
| Fabricant | JAMP PHARMA CORPORATION | AVET LIFESCIENCES LTD |
Ondansetron (INN: ONDANSETRON, ATC A04AA01) and Metoclopramide (INN: METOCLOPRAMIDE HYDROCHLORIDE, ATC A03FA01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ces informations sont à titre éducatif uniquement. Elles ne constituent pas un avis médical. Consultez toujours un professionnel de santé qualifié.